Analysis About The Pathogen Distribution And Antibiotic Resistance Of Bacteria In The Patients With AECOPD

Chronic obstructive pulmonary disease is characterized by poorlyreversible airflow limitation, while the airflow limitation wil l become more andmore severe. During the progressive deterioration up to end -stage COPD, acuteexacerbations of chronic obstructive pulmonary disease (AECOPD) usuallyoccur. When the complications take place, such as respiratory failure,pulmonary encephalopathy, disseminated introvascular coagulation and shock,the life quality of the patients with AECOPD will be greatly affected. Also theacute exacerbation of COPD is a common cause of mortality. And therespritory infection is the important reason for t he AECOPD. Threrfore, usingthe antibiotic to control the infection is an important meas of AECOPD. Butbecause of the abuse of the antibiotics now and the lower immunity of the mostpatients who are hospital -acquired infective, the growing bacteria resist ancehas become a very difficult issue. And this difficult issue has brought an newchallenge to the doctor. So detecting the pathogen and acknowle dging thebacteria resistance is very important for the treatment and the prognosis ofAECOPD.The objects are the 725 patients with AECOPD, who had hospitalized inthe respiratory department of our hospital from January 2005 to October 2007.There are 369men and 356 women. Th eir age ranges from 20 to 93, and theiraverage age is 69.12. The internist collects th e patients'phlegm and send thecollecting phlegm to the microbial laboratory in one hour. The doctors in themicrobial lab cultivate the phlegm, choose the suspicious bacteria and perform the aitibiotic sensitivity test. Then account pathogens and calculat e the drugresistant rate of Gram-negative bacteria and Gram-positive bacteria.The research shows that there are 211 patients whose phlegm was sendedto the lab in 725 patients, the check rate is 29.10%. The phlegm cultivationamount is 258, but the phlegm cultivation positive amout is 141, the positiverate is 53. 24%. we bred and separate 138 bacteria. There are 58 fungi, whichhave a rate of 46.38% in all pathogen, the main pathogen is Candida albicans;and 67 Gram-negative bacteria, which have a rate of 48.55%, the main bacteriawas Pseudomonas, Acinetobacter and Klebsiella; and 13 Gram -positivebacteria. Gram-negative bacteria have high rate of drug resistance to the secondgeneration cephalosporins. The rate of the resistance to cefuroxime is 64.10%.Gram-negative bacteria also have high rate of drug resistance to the thirdgeneration cephalosporins. The rate of the resistance to cefoperazone is 45.45%.But ceftazidime is sensitive to the Gram- negative bacteria, the resistance rateis only 19.48%. The fourth generation cephalosporins, quinolones andaminoglycosides are sensitive to the Gram -negative bacteria, the resistance rateis below 23.0%. Amoxicillin/clavulanic acid and ampicillin/sulbactam havehigh resistant rate to the Gram-negative bacteria, and the resistant rate is above57.63%. But ticarcillin/clavulanic acid and piperacillin/tazobactam aresensitive to Gram-negative bacteria, and the resistant rate is below 24.62%.Imipenem is highly sensitive to the Gram -negative bacteria, the resistant rate isbelow 12.99%. Gram-positive bacteria are resistant to penicillin, thecompliance of penicillin and the enzyme inhibitor, cephalosporins, quinolonesantibiotic, cotrimoxazole and erythromycin. The resistant rate is above 70.83%.But Gram-positive bacteria are sensitive to amikacin, chloramphenicol, minocycline and furans. The resistant rate is below 20.00%. Gram-positivebacteria are 100% sensitive to vancomycin.The research shows that the check rate and the detection rate of phelgmcultivation in clinic was low at present. The clinician should actively improvethe patient's assistant check. Every patient with AECOPD in the hospitalshould do the sputum cultivation. And we need to notice the quality of thephlegm. The phlegm should be the second phleg m which is morning phlegmafter gargling and should be checked in 1 hour. And also we shluld improve theseparate method and construct the advanced microorganism lab. After thisresearch we know that the composing proportion of the pathogens in clinicchanged. The main pathogen are Gram-negative bacteria and fungi. Theresistance of Gram-negative bacteria which the clinicians should pay moreattention to become severe. The clinicians should choose the fourth generationcephalosporins, fourth generation quinolone, Imipenem, ticarcillin/clavulanicacid and piperacillin/tazobactam for treating the severe AECOPD. Theclinicians should reasonably use the antibiotic in order to avoid superinfectionand reduce the formation of resistance.In abstracto every patient with AECOPD in the hospital should do thesputum cultivation , and doctor should choose the antibiotics basing on thecultivation result. But in clinic the antibiotic is used based on the experiencebefore the result of sputum cultivation and the antibiot ic sensitivity test. Thesuccessful experience of medication is usually built on the prevalence ofpathogens investigation, monitoring, as well as durg resistance and treatmentgoals established on the basis of the programme. Strictly speaking, empiricaltreatment can not only rely on the clinicians'ideas, it should base on the actual situation. The doctors choose the antibiotics and strictly control the dose andtreatment time of antibiotics in order to prevent the abuse of antibiotics toreduce the emergence of drug resistance. The monitoring of the bacteriaresistance is the important methed to acknowledge the change of bacteriadistribution and resistance. Understanding of the bacterial resistance is in favorof the reasonable choice of antibiotic, and t his will reduce and delay theformation of the durg resistance and improve the quality of the treatment forthe infectious diseases.The conclusion: at present the check rate and the detection rate of sputumcultivation in clinic was low. The main pathogen s of the patients withAECOPD are Gram-negative bacteria and fungi. The resistance ofGram-negative bacteria is very severe. Gram-negative bacteria are resistant tothe second and third generation cephalosporin, but are sensitive to the fourthgeneration cephalosporin, Quinolones and Animoglycoside antibiotics. Alsothey are sensitive to the complex of the penicillins and lactanase inhibitor,imipenem. Gram-positive bacteria are resistant to the penicillins,Cephalosporin, Quinolones, but they are sensitiv e to the anmioglycosidantibiotic and chloramphenicol, and are 100% sensitive to the vancocin. T heclinicians should choose the fourth generation cephalosporins, fourthgeneration quinolone, Imipenem, ticarcillin/clavulanic acid andpiperacillin/tazobactam for treating the severe AECOPD. The doctor shoulddynamicly surveil the chang of pathogen and antibiotic resistance to providethe basis for clinical treatment with experiecce.